En este ensayo clnico aleatorizado, doble ciego y controlado con placebo, que form parte del programa clnico de Novo Nordisk, los adultos con sobrepeso u obesidad lograron una reduccin media del 15,2 % del peso corporal frente al 2,6 % en el grupo placebo, adems de mejoras sostenidas en factores metablicos
That's a provider conversation, and it's exactly what a free discovery call is for
In a Phase 2 randomised controlled trial published in The New England Journal of Medicine (Jastreboff et al., 2023), participants without type 2 diabetes receiving the highest doses of retatrutide achieved mean body weight reductions of approximately 24% over 48 weeks
True generic semaglutide wont be available until patents expire around 2032
However, for some people, these side effects can feel challenging
Patients report faster treatment starts, clearer pricing, and simplified monthly billing compared to insurance-dependent alternatives